Neoadjuvant Treatment of Tislelizumab Combined Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma ：A Single-arm, Prospective, Phase II Trial

Abroad (travel likely)RecruitingPHASE2

Conditions

Oral Squamous Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

First affiliated hospital, School of Medicine, Zhejiang University, Hangzhou, China
Contact: Study coordinator (Weijia Fang, Doctor)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC

Oral Squamous Cell Carcinoma · Neoadjvant Therapy · Anti-PD-1

Abroad (travel likely)RecruitingPHASE2, PHASE3

Shanghai, China

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Diffuse Astrocytoma, IDH-Mutant · Glioblastoma, IDH-wildtype · Brain Metastases, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beverly Hills, United States · Glendale, United States

Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy

Carcinoma · Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Fullerton, United States · Los Angeles, United States

A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)

Squamous Cell Carcinoma of Head and Neck · Sinus Cancer · Nasal Cavity Cancer

Abroad (travel likely)RecruitingPHASE2

Basking Ridge, United States · Middletown, United States